caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1891806543

Giacomina Massaro-GiordanoMD

OphthalmologyPhiladelphia, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Giacomina Massaro-Giordano's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
PRESBYTERIAN MEDICAL CENTER OF THE UNIVERSITY OF PENNSYLVANIA HEALTH S193576
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
32111
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
1645
THE PENNSYLVANIA HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA HEALTH SYS1655
MAIN LINE HOSPITALS, INC.1547
Stephen Orlin
Ophthalmology · Philadelphia, PA
1233
PHILADELPHIA POST ACUTE PARTNERS, LLC1124
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
902
Unique beneficiaries
—
Total services
1,040
Distinct HCPCS
4
Medicare payment
$70K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 810 Ophthalmology providers in PA — below median (cohort median 1,854).
PRESCRIBING · PART D · 2024
Total Rx claims
3,374
Beneficiaries
—
Total drug cost
$2.3M
Distinct drugs
19
Brand share
90.9%
Top prescribed drugs
Erythromycin Base1,287 claims
Tobramycin/Dexamethasone821 claims
Perfluorohexyloctane/Pf253 claims
Cyclosporine181 claims
Cyclosporine120 claims
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
73.6
Cost
76.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.42%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$23K
Payment records
12
By payment type
Travel and Lodging$15K
Consulting Fee$7K
Food and Beverage$890